81 related articles for article (PubMed ID: 1419951)
1. Hodgkin's disease derived cell lines: a review.
Drexler HG; Minowada J
Hum Cell; 1992 Mar; 5(1):42-53. PubMed ID: 1419951
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease-derived cell lines--conflicting clues for the origin of Hodgkin's disease?
Drexler HG; Amlot PL; Minowada J
Leukemia; 1987 Sep; 1(9):629-37. PubMed ID: 3312848
[TBL] [Abstract][Full Text] [Related]
3. Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines.
Drexler HG; Leber BF; Norton J; Yaxley J; Tatsumi E; Hoffbrand AV; Minowada J
Leukemia; 1988 Jun; 2(6):371-6. PubMed ID: 3131596
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.
Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F
Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications.
Diehl V; Pfreundschuh M; Fonatsch C; Stein H; Falk M; Burrichter H; Schaadt M
Cancer Surv; 1985; 4(2):399-419. PubMed ID: 3842319
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
Hsu SM; Yang K; Jaffe ES
Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
[TBL] [Abstract][Full Text] [Related]
8. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.
Drexler HG
Leuk Lymphoma; 1993 Jan; 9(1-2):1-25. PubMed ID: 7682880
[TBL] [Abstract][Full Text] [Related]
9. Identification of an Mr 70,000 antigen associated with Reed-Sternberg cells and interdigitating reticulum cells.
Hsu PL; Hsu SM
Cancer Res; 1990 Jan; 50(2):350-7. PubMed ID: 2153049
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
McKenzie JL; Egner W; Calder VL; Hart DN
Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
[TBL] [Abstract][Full Text] [Related]
11. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
[TBL] [Abstract][Full Text] [Related]
12. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
[TBL] [Abstract][Full Text] [Related]
13. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
[TBL] [Abstract][Full Text] [Related]
14. Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues.
Hsu PL; Lin YC; Hsu SM
Int J Hematol; 1991 Aug; 54(4):315-26. PubMed ID: 1838015
[TBL] [Abstract][Full Text] [Related]
15. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
17. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
[TBL] [Abstract][Full Text] [Related]
19. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
20. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
